Package 72336-073-30

{"route": ["ORAL"], "spl_id": "1540d100-da32-4a84-98d9-a9088d2628ea", "openfda": {"nui": ["N0000175817", "N0000175818"], "upc": ["0372336073301"], "unii": ["4AF302ESOS"], "rxcui": ["2685489"], "spl_set_id": ["c66d63cf-a0e5-4cb5-bdf8-9d1115cba23e"], "pharm_class_epc": ["Serotonin-3 Receptor Antagonist [EPC]"], "pharm_class_moa": ["Serotonin 3 Receptor Antagonists [MoA]"], "manufacturer_name": ["Lifsa Drugs LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (72336-073-30)", "package_ndc": "72336-073-30", "marketing_start_date": "20240620"}], "brand_name": "Ondansetron", "product_id": "72336-073_1540d100-da32-4a84-98d9-a9088d2628ea", "dosage_form": "TABLET, ORALLY DISINTEGRATING", "pharm_class": ["Serotonin 3 Receptor Antagonists [MoA]", "Serotonin-3 Receptor Antagonist [EPC]"], "product_ndc": "72336-073", "generic_name": "Ondansetron", "labeler_name": "Lifsa Drugs LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Ondansetron", "active_ingredients": [{"name": "ONDANSETRON", "strength": "16 mg/1"}], "application_number": "ANDA077406", "marketing_category": "ANDA", "marketing_start_date": "20061226", "listing_expiration_date": "20261231"}